Clinical study of oncogenic mutations in the PI3K/PTEN/AKT pathway reported both the data on mutually exclusive of PTEN loss and PIK3CA mutation in human breast (58) and gastric (59) carcinomas and frequently concordant in breast cancer (43, 44). Here, AKT1 is linked to breast carcinoma.